EZH2 and central nervous system cancer: The statistical analysis illustrated that the EZH2/p65 axis was dramatically relative to age, glioma grades and EGFR expression, suggesting that high levels of both p65 and EZH2 expression are correlated to a higher risk of glioblastoma development and progression (Supplementary Table 2).